Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint by Zhou, Jun et al.
Minor Alteration of Microtubule Dynamics Causes Loss of Tension
across Kinetochore Pairs and Activates the Spindle Checkpoint*
Received for publication, October 29, 2001, and in revised form, February 21, 2002
Published, JBC Papers in Press, February 25, 2002, DOI 10.1074/jbc.M110369200
Jun Zhou‡§, Dulal Panda¶, Jaren W. Landen§, Leslie Wilson¶, and Harish C. Joshi‡§**
From the ‡Graduate Program in Biochemistry, Cell and Developmental Biology and the §Department of Cell Biology,
Emory University School of Medicine, Atlanta, Georgia 30322 and the ¶Department of Molecular, Cellular,
and Developmental Biology, University of California, Santa Barbara, California 93106
We have previously identified the opium alkaloid
noscapine as a microtubule interacting agent that binds
stoichiometrically to tubulin and alters its conforma-
tion. Here we show that, unlike many other microtubule
inhibitors, noscapine does not significantly promote or
inhibit microtubule polymerization. Instead, it alters
the steady-state dynamics of microtubule assembly, pri-
marily by increasing the amount of time that the micro-
tubules spend in an attenuated (pause) state. Further
studies reveal that even at high concentrations, noscap-
ine does not alter the tubulin polymer/monomer ratio in
HeLa cells. Cells treated with noscapine arrest at mito-
sis with nearly normal bipolar spindles. Strikingly, al-
though most of the chromosomes in these cells are
aligned at the metaphase plate, the rest remain near the
spindle poles, both of which exhibit loss of tension
across kinetochore pairs. Furthermore, levels of the
spindle checkpoint proteins Mad2, Bub1, and BubR1 de-
crease by 138-, 3.7-, and 3.9-fold, respectively, at the kin-
etochore region upon chromosome alignment. Our re-
sults thus suggest that an exquisite control of
microtubule dynamics is required for kinetochore ten-
sion generation and chromosome alignment during mi-
tosis. Our data also support the idea that Mad2 and
Bub1/BubR1 respond to kinetochore-microtubule at-
tachment and/or tension to different degrees.
Microtubules are cytoskeletal structures assembled from
/-tubulin heterodimers that play an essential role in many
cellular processes, such as cell motility, organelle transport,
maintenance of cell polarity, and cell division (1). Microtubules
are intrinsically dynamic, in that they alternate abruptly and
stochastically between periods of growth and shortening, a
phenomenon termed “dynamic instability” (2, 3). A second dy-
namic behavior of microtubules, termed “treadmilling,” results
from the net growth of microtubules at one end and net short-
ening at the other end (4). Several parameters have been used
to characterize the dynamics of microtubule assembly: growth
rate, shortening rate, frequency of transition from growth to
shortening (catastrophe frequency (5)), frequency of transition
from shortening to growth or an attenuated (pause) state (res-
cue frequency (5)), and the duration of the attenuated state
when neither microtubule growth nor shortening can be de-
tected (6). Overall microtubule dynamics due to dynamic insta-
bility is best described as “dynamicity,” which measures the
sum of visually detectable tubulin dimer exchange per unit
time at the ends of microtubules.
These dynamic properties are crucial for microtubules to
carry out many of their cellular functions such as reorientation
of the microtubule network when cells undergo migration or
morphological changes and the dramatic microtubule rear-
rangement at the onset of mitosis (7). Mitotic microtubules are
10–100 times more dynamic than interphase microtubules;
they exchange their tubulin with the soluble tubulin pool with
half-times of 15 s during mitosis as compared with 3 min to
several hours in interphase (8–11). The rapid microtubule dy-
namics in mitosis is thought to be critical for both the morpho-
genesis and activities of the bipolar spindle, which directs the
alignment of chromosomes at the metaphase plate and their
final segregation into two daughter cells.
Many microtubule interacting agents have been very useful
in the study of mitosis because they bind to microtubules and
disrupt their normal activities. One group of agents, such as
paclitaxel, promotes microtubule polymerization at high con-
centrations and bundles the resulting stable microtubules. An-
other group, including colchicine, nocodazole, and vinblastine,
inhibits microtubule polymerization at high concentrations and
suppresses microtubule dynamics at low concentrations (6).
Although these different classes of microtubule inhibitors act
differently, they all block cell cycle progression at promet-
aphase, thus preventing onset of the metaphase-anaphase
transition. It is generally believed that these agents cause
spindle damage or suppress spindle dynamics, consequently
activating the spindle checkpoint to block cells at mitosis (6,
12). In its role as a molecular safeguard, the spindle checkpoint
might be able to sense even minor errors in spindle function.
Consequently, drugs that alter spindle dynamics without
changing microtubule polymer mass would be powerful tools
for studying the roles of microtubule dynamics in mitosis and
for refining the mechanisms for spindle checkpoint activation.
We have previously found that the opium alkaloid noscapine
binds stoichiometrically to tubulin, alters the conformation of
tubulin, and arrests mammalian cells at mitosis without caus-
ing gross deformations of cellular microtubules (13). In this
study we demonstrate that noscapine suppresses the steady-
state dynamics of microtubule assembly without significantly
affecting microtubule polymerization in vitro or in tissue cul-
ture cells even at high concentrations. Our data also show
clearly that minor alteration of microtubule dynamics by
noscapine causes failure of chromosome congression and loss of
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tension across sister kinetochores and activates the spindle
checkpoint. These findings not only provide important insight
into the mechanism by which noscapine blocks mitotic progres-
sion but also shed light on the molecular basis of how the
kinetochore tension is generated and how the spindle check-
point proteins respond to microtubule attachment and/or
tension.
EXPERIMENTAL PROCEDURES
Materials—Bovine brain microtubule proteins were isolated without
glycerol by three cycles of polymerization and depolymerization. Tubu-
lin was purified from the microtubule proteins by phosphocellulose
chromatography as described previously (14). The tubulin solution was
quickly frozen as drops in liquid nitrogen and stored at 70 °C until
use. Protein concentration was determined by the method of Bradford
(15) using bovine serum albumin (BSA)1 as the standard. Noscapine
(97% purity) was purchased from Aldrich. The noscapine stock solution
was prepared at 100 mM in dimethyl sulfoxide (Me2SO) and stored at
20 °C until use. Paclitaxel, nocodazole, and vinblastine were all from
Sigma and dissolved in Me2SO as 10 mM stock solutions.
Cell Culture—HeLa cells were maintained in Dulbecco’s modified
Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine se-
rum (Invitrogen) at 37 °C in a 5% CO2, 95% air atmosphere. Cells were
grown as monolayers in tissue culture plates or on glass coverslips.
In Vitro Assembly of Tubulin Subunits—Spectrophotometer cuvettes
(0.4-cm path length) held a solution consisting of microtubule assembly
buffer (100 mM Pipes, 2 mM EGTA, 1 mM MgCl2, 1 mM GTP, pH 6.8) and
1, 10, or 100 M noscapine, 10 M paclitaxel, 10 M nocodazole, or the
solvent Me2SO. The cuvettes were kept at room temperature before the
addition of 10 M purified tubulin and shifted to 37 °C in a temperature-
controlled Ultrospec 3000 spectrophotometer (Amersham Biosciences).
The assembly was monitored by measuring the changes in absorbance
(350 nm) at 0.5-min intervals.
Measurement of Microtubule Dynamics—Bovine brain tubulin was
mixed with sea urchin flagellar axoneme seeds and polymerized in
PMME buffer (87 mM Pipes, 36 mM MES, 1.8 mM MgCl2, 1 mM EGTA,
pH 6.8) containing 1 mM GTP in the absence or presence of different
concentrations of noscapine. The seed concentration was adjusted to
achieve 3–6 seeds/microscopic field. After 35 min of incubation, samples
of microtubule suspensions (2.5 l) were prepared for videomicroscopy,
and the dynamics of individual microtubules were recorded at 37 °C as
described previously (16, 17). Microtubules were observed for a maxi-
mum of 45 min after reaching steady state. Under the experimental
conditions used, microtubule growth occurred predominantly at the
plus ends of the seeds as determined by the growth rates, the number
of microtubules that grew, and the relative lengths of the microtubules
at the opposite ends of the seeds (5, 14, 16–19).
Microtubule length changes were analyzed as described previously
(16, 17). We considered the microtubule to be in a growing phase if the
microtubule increased in length by 0.2 m at a rate of 0.15 m/min,
and in a shortening phase if the microtubule shortened in length by
0.2 m at a rate of0.3 m/min. Length changes equal to or less than
0.2 m over the duration of 6 data points were considered as attenua-
tion (pause) phases. We used the same tubulin preparation for all
experiments, and an average of 25–30 microtubules was measured for
each experimental condition. The catastrophe frequency was calculated
by dividing the number of catastrophes by the sum of the total time
spent in the growing plus attenuated state for all microtubules for a
particular condition. Similarly, the rescue frequency was calculated by
dividing the total number of rescue events by the total time spent
shortening for all microtubules for a particular condition.
Preparation of Polymeric (Cytoskeletal) and Monomeric (Soluble) Tu-
bulin—Cells were washed, and soluble proteins were then extracted
under conditions that prevent microtubule depolymerization (0.1% Tri-
ton X-100, 0.1 M MES, pH 6.75, 1 mM MgSO4, 2 mM EGTA, 4 M glycerol)
(20). The remaining cytoskeletal fraction in the culture dish was dis-
solved in 0.5 ml of 0.5% SDS in 25 mM Tris (pH 6.8). Total protein
concentration was then determined in each fraction by BCA reagents
(Pierce). Equivalent amounts for each treatment group were loaded on
the gel and stained with Coomassie Blue. A duplicate gel was then
transferred for Western blot analysis using monoclonal anti--tubulin
antibody (Sigma).
Western Blot Analysis—Proteins extracted from mammalian cells
were analyzed by polyacrylamide gel electrophoresis as described (21),
and the protein bands were electrophoretically transferred onto polyvi-
nylidene difluoride membranes (Millipore, Bedford, MA). The mem-
branes were incubated first with primary antibodies and then with
horseradish peroxidase-labeled secondary antibodies. Specific proteins
were visualized using enhanced chemiluminescence following manufac-
turer’s instructions (Amersham Biosciences). The relative protein levels
were determined by densitometric analysis using a Lynx video densi-
tometer (Biological Vision Inc., San Mateo, CA).
1 The abbreviations used are: BSA, bovine serum albumin; Pipes,
1,4-piperazinediethanesulfonic acid; MES. 4-morpholineethanesulfonic
acid; PBS, phosphate-buffered saline.
FIG. 1. Noscapine does not significantly affect the assembly of
tubulin into microtubules in vitro. The effects of different concen-
trations of noscapine on tubulin polymer formation were measured by
light scattering, reflected as the absorbance at 350 nm wavelength. For
purposes of comparison, 10 M paclitaxel and nocodazole were also
used. Note that the A350 scattering by the polymerization of tubulin over
time in the presence of 1 M noscapine overlapped with that of the
control, indicating that 1 M noscapine did not affect the rate or extent
of microtubule assembly.
FIG. 2. Life history plots of representative in vitro assembled
microtubules at their plus ends at steady state in the absence
(A) or presence of 20 M noscapine (B). The lengths of individual
microtubules were measured from real-time videotape recordings as
described under “Experimental Procedures.”
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Flow Cytometric Analysis—The flow cytometric evaluation of the cell
cycle status was performed as previously described (13). Briefly, 2 106
HeLa cells were centrifuged, washed twice with ice-cold phosphate-
buffered saline (PBS), and fixed in 70% ethanol. Tubes containing the
cell pellets were stored at 20 °C for at least 24 h. After this, the cells
were centrifuged at 1000  g for 10 min, and the supernatant was
discarded. The pellets were resuspended in 30 l of phosphate/citrate
buffer (0.2 M Na2HPO4/0.1 M citric acid, pH 7.5) at room temperature for
30 min. Cells were then washed with 5 ml of PBS and incubated with
propidium iodide (20 g/ml)/RNase A (20 g/ml) in PBS for 30 min.
Samples were analyzed on a Coulter Elite flow cytometer (Beckman
Coulter, Inc., Fullerton, CA).
Immunofluorescence Microscopy—To visualize microtubules, HeLa
cells grown on glass coverslips were fixed with cold (20 °C) methanol
for 5 min and then washed with PBS for 5 min. Nonspecific sites were
blocked by incubating with 100 l of 2% BSA in PBS at 37 °C for 15 min.
A mouse monoclonal antibody against -tubulin (DM1A, Sigma) was
diluted 1:500 in 2% BSA in PBS and incubated (100 l) with the
coverslips at 37C for 2 h. Cells were then washed with 2% BSA/PBS for
10 min at room temperature before incubating with a 1:100 dilution of
a fluorescein-labeled donkey anti-mouse IgG antibody (Jackson Immu-
noResearch, Inc., West Grove, PA) at 37 °C for 1 h. Coverslips were then
rinsed with 2% BSA/PBS for 10 min and incubated with propidium
iodide for another 10 min at room temperature before they were
mounted with AquaMount (Lerner Laboratories, Pittsburgh, PA) con-
taining 0.01% 1,4-diazobicyclo(2,2,2)octane (DABCO, Sigma). Cells
were examined with a Zeiss Axiovert 135 fluorescence microscope using
a 100/1.3 oil lens (Plan-Neofluar, Carl Zeiss, Inc., Thornwood, NY).
To visualize the spindle checkpoint proteins Mad2, Bub1, and
BubR1, HeLa cells were grown on poly-L-lysine-coated glass coverslips
and fixed with 1% paraformaldehyde/PBS for 20 min at room temper-
ature. Coverslips were then washed with PBS for 5 min, permeabilized
with 0.2% Triton X-100/PBS for 2 min, and washed for another 5 min
with PBS before they were processed for incubation with primary and
secondary antibodies, stained with propidium iodide, and examined
microscopically as described above. Rabbit polyclonal anti-Mad2 anti-
body was obtained from Dr. E. D. Salmon (University of North Caro-
lina) and used at a 1:200 dilution. Rabbit polyclonal anti-Bub1 and
mouse monoclonal anti-BubR1 antibodies were from Dr. T. J. Yen (Fox
Chase Cancer Institute) and used at 1:1000 and 1:1200 dilutions, re-
spectively. Fluorescein-labeled donkey anti-rabbit and donkey anti-
mouse IgG antibodies were from Jackson ImmunoResearch and used at
1:100 dilutions.
Analysis of the Integrated Intensity of Kinetochore Fluorescence—The
integrated intensity of immunofluorescently stained kinetochores was
measured using a method developed initially by King et al. (22) and
described in detail by Hoffman et al. (23). All images were taken from
the stacks of 12-bit confocal images using the LSM510 imaging software
(Carl Zeiss). Images did not require deconvolution because of the suffi-
cient focal depth of the numerical aperture of the 100/1.4 Plan-
Neofluar objective to capture most, if not all, kinetochore fluorescence
intensity (22, 23). Two computer-generated squares, called the inner
and outer squares, respectively, were centered outside of each kineto-
chore (Fig. 9A). They represented 38  38 and 48  48 pixels2, respec-
tively. The 38  38-pixel region was designated as the 0.76  0.76
m2-area, which was large enough to contain the majority of kineto-
chore fluorescence in HeLa cells. To correct for the background fluores-
cence, we chose to measure the fluorescence intensity in a square region
5 pixels away from the periphery of the inner square. The total inte-
grated fluorescence counts within each square were recorded, and the
data were transferred to Microsoft Excel. The measured fluorescence of
the 38  38-pixel region included the kinetochore fluorescence and the
background fluorescence, whereas the fluorescence within the region
between perimeter of outer and inner squares included mostly the
background fluorescence. This allowed us to correct for the real kine-
tochore fluorescence (see the diagram and equation in Fig. 9A).
Measurement of Sister Kinetochore Distance—Cells grown on glass
coverslips were treated with 20 M noscapine or 6.7 nM vinblastine for
4 h and then fixed with 2% paraformaldehyde/PBS, permeabilized with
0.2% Triton X-100/PBS, and processed with primary and secondary
antibodies as described above. Anti-human centromere antibodies
(hACA) were kindly provided by Dr. K. F. Sullivan (Scripps Research
Institute) and used at 1:100 dilution to visualized centromeres. Mono-
clonal antibodies against -tubulin (DM1A, Sigma) were also used to
identify mitotic figures. Fluorescein-labeled donkey anti-human and
rhodamine-labeled donkey anti-mouse IgG antibodies were from Jack-
son ImmunoResearch and used at 1:100 dilutions. The center-to-center
distances between sister kinetochores were measured from 12-bit con-
focal image stacks. When sister kinetochores were in the same focal
plane, the real inter-kinetochore distance (d) equals the measured
distance between the two sister kinetochores (y). When sister kineto-
chores were not in the same focal plane, the inter-kinetochore distance
(d) was corrected by triangulation of the measured distance (y) and the
z axis distance (z) between two focal planes containing the brightest
staining for each of the two sister kinetochores (Ref. 24; also see the
diagram and equation in Fig. 6B).
RESULTS
Effects of Noscapine on the Assembly of Tubulin Sub-
units—We have previously shown that noscapine binds to tu-
FIG. 3. Effects of noscapine on the tubulin polymer/monomer
ratio in HeLa cells. A, Coomassie Blue staining of the proteins in cell
extracts containing polymeric (P) or monomeric/soluble (S) tubulin.
Cells were treated with 1, 10, 100 M noscapine, 10 M paclitaxel, 10 M
nocodazole, or the equivalent amount of the solvent Me2SO for 4 h, and
cell extracts were then isolated as described (20). B and C, Western blot
analysis showing polymeric and monomeric tubulin in the cells de-
scribed in A. In C, cell extracts were loaded at a 1.25-fold serial dilution
starting from 30 g of protein to ensure measurement in the linear
range of detection. D, quantitation by densitometry of the fraction of
polymeric tubulin in cells treated under different drug conditions. Al-
though paclitaxel increases tubulin in the polymeric fraction and no-
codazole increases tubulin in the soluble fraction, noscapine causes no
detectable changes in polymeric or soluble tubulin fractions.
TABLE I
Effects of noscapine on the dynamic instability parameters of
microtubule plus ends at steady state
Parameter
Noscapine
0 M 20 M 50 M
Rate (m/min)
Growing rate 0.92  0.08 0.60  0.06 0.53  0.03
Shortening rate 18.5  2.3 14.5  2.1 14.0  2.8
Percent of total time (%)
Growing 84.1 89.5 81.3
Shortening 11.5 3.8 6.0
Attenuation 4.4 6.7 12.7
Transition frequency (min1)
Catastrophe 0.44  0.10 0.13  0.03 0.23  0.05
Rescue 1.76  0.12 2.20  0.63 3.20  0.74
Dynamicity (m/min) 2.4 0.90 0.91
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bulin with a stoichiometry of 1 (0.95  0.02) noscapine mole-
cule/tubulin dimer and induces conformational changes in
tubulin upon binding (13). In addition, when incubated with
cultured mammalian cells, noscapine significantly increases
the mitotic index and blocks cell proliferation, indicating an
arrest in mitosis (13). It is conceivable that the mitotic arrest
caused by noscapine may result from the suppression of micro-
tubule dynamics and not the action of noscapine on the extent
of tubulin polymerization. To test this hypothesis, we first
examined the effect of noscapine on the assembly of tubulin
subunits into microtubules in vitro by measuring changes in
the turbidity produced upon tubulin polymerization in the
presence of noscapine. 1 M noscapine did not have a detectable
effect on tubulin assembly, showing an absorbance curve over-
lapping that of the solvent control (Fig. 1). At concentrations of 10
and 100 M, noscapine only slightly increased the extent of mi-
crotubule polymerization. In contrast, 10 M paclitaxel strongly
promoted microtubule polymerization, and 10 M nocodazole
strongly inhibited microtubule polymerization (Fig. 1).
Effects of Noscapine on Microtubule Dynamic Instability at
Steady State—We next studied the effect of noscapine on the
steady-state dynamic instability behavior of microtubules assem-
bled in vitro from purified tubulin by video microscopy. Microtu-
bule growth occurred predominantly at the plus ends of the seeds
as determined by the growth rates, the number of microtubules
that grew, and the relative lengths of the microtubules at the
opposite ends of the seeds. Several life history traces of microtu-
bule length changes in the absence of noscapine are shown in Fig.
2A. As expected, microtubules alternated between phases of
growing and shortening, and also spent a small fraction of time in
FIG. 4. Noscapine arrests HeLa cells
at mitosis. A, immunofluorescence mi-
crographs of microtubule arrays and DNA
in HeLa cells untreated or treated with 20
M noscapine for 12 h. In the set of panels
showing noscapine treatment, the lens
was focused on mitotic cells to highlight
the chromosome alignment failure caused
by noscapine. As a result, the flat inter-
phase cells were slightly out of focus.
Bars, 10 m. B, flow cytometric analysis
of DNA content in HeLa cells untreated
(left) or treated with noscapine (right).
Noscapine treatment resulted in a clear
increase in the percentage of cells with a
duplicated complement of DNA (4N).
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an attenuated state, neither growing nor shortening to a detect-
able extent. The addition of 20 M noscapine suppressed micro-
tubule dynamics (Fig. 2B). It reduced the growing and shortening
rates and increased the percentage of time that the microtubules
spent in the attenuated state.
The actions of noscapine on the individual dynamic instabil-
ity parameters at steady state were determined quantitatively
(Table I). Noscapine slightly suppressed the growing rate of
microtubule plus ends. For example, the mean growing rate in
the absence of noscapine was 0.92 m/min, and the addition of
20 M noscapine reduced the growing rate to 0.60 m/min.
Even at the high concentration of 50 M, noscapine reduced the
mean growing rate by only 42.4%. Similar to its effects on
microtubule growth, noscapine also slightly affected the rate
and extent of microtubule shortening (Table I). For example, in
the presence of 20 and 50 M noscapine, the shortening rate
was reduced by 21.6 and 24.3%, respectively. In addition,
noscapine reduced the percentage of time microtubules spent
in the shortening phase (Table I).
Microtubules, both in vitro and in cells, spend a considerable
fraction of time in an attenuated (pause) phase at or near
steady state (6, 14, 19, 25). Strikingly, noscapine increased the
percentage of time that the microtubules spent in the attenu-
ated state (Table I). For example, in the presence of 50 M
noscapine, microtubules spent 12.7% of the time in the atten-
uated state, which is a 1.9-fold increase compared with micro-
tubules in the absence of noscapine.
The transition frequencies among the growing, shortening,
and attenuated states are considered important in the regulation
of microtubule dynamics in cells (11, 26). Noscapine strongly
decreased the catastrophe frequency and increased the rescue
frequency (Table I). Dynamicity is a parameter that reflects the
overall dynamics of the microtubules (the total detectable tubulin
dimer addition and loss at a microtubule end (6, 14, 25)). As
shown in Table I, 20 and 50 M noscapine suppressed microtu-
bule dynamicity by 62.5 and 62.1%, respectively.
Noscapine Does Not Change Tubulin Polymer/Monomer Ra-
tio in Cells—The moderate suppression effects of noscapine on
microtubule dynamics in vitro and its subtle effect on microtu-
bule polymerization predicted that unlike paclitaxel, nocoda-
zole, or vinblastine, noscapine might not significantly change
the tubulin polymer/monomer ratio in vivo at high concentra-
tions. To test this hypothesis, we prepared cell extracts that
contain cytoskeletal (polymeric) and soluble (monomeric) tubu-
lin, respectively, from HeLa cells treated with different concen-
trations of noscapine and performed a quantitative Western
blot analysis as shown in Fig. 3. The percentage of polymeric
tubulin in cells treated with 1, 10, and 100 M noscapine was
58.3, 59.2, and 59.2%, respectively. These values are very sim-
ilar to that in control cells that were treated with the equiva-
lent amount of the solvent Me2SO (59.4%). In contrast, as
expected, for cells treated with 10 M paclitaxel, 99.6% of
tubulin was in the polymeric form, and for those cells treated
with 10 M nocodazole, only 12.1% of the tubulin was poly-
meric. Thus, although paclitaxel increased tubulin in the pol-
ymeric fraction and nocodazole increased tubulin in the mono-
meric fraction, noscapine induced no measurable increase or
decrease of tubulin in the polymeric or monomeric fractions.
Chromosome Alignment Failure in Noscapine-arrested Mi-
totic Cells—We have previously found that, similar to other
microtubule interacting agents, noscapine arrests mammalian
cells at mitosis (13). However, unlike many known microtubule
inhibitors, noscapine does not cause gross deformations of cel-
lular microtubules. This discovery led us to explore the effect of
noscapine during mitosis. At low concentrations (e.g. 1 M),
noscapine could not arrest mitosis even after a 36-h treatment.
10 M noscapine did have an effect on mitotic arrest, but the
efficiency was quite low (17.6% for a 24-h treatment). However,
when noscapine concentration was increased up to 20 M, its
effect on mitotic arrest was much clearer (70.2% for a 24-h
treatment). As shown in Fig. 4A, following a 12-h treatment
with 20 M noscapine, many human HeLa cells were arrested
at mitosis with condensed chromosomes. This arrest was ac-
companied by an increased fraction of cells with 4N DNA
content, as revealed by a fluorescence-activated cell sorting
assay (Fig. 4B). Interestingly, mitotic arrested cells resulting
from treatment with 20 or even 100 M noscapine formed
nearly normal bipolar spindles (Figs. 4 and 5). Higher concen-
trations of noscapine were not applicable because of the low
solubility of noscapine in the culture medium.
In addition, we found that in noscapine-arrested HeLa cells,
although most of the chromosomes were aligned at the equa-
torial metaphase plate, the remaining chromosomes were pres-
ent near the spindle poles (Fig. 5). This action of noscapine is
not only similar to when microtubule dynamics are suppressed
by nanomolar concentrations of vinblastine and paclitaxel (Ref.
6, also see Fig. 5) but also to when the kinetochore motor
CENP-E is lacking (27–30). These results suggested that chro-
mosome congression and subsequent alignment at the met-
aphase plate might require an exquisite control of microtubule
dynamics. Noscapine, although causing only a slight alteration
of microtubule dynamics in vitro, appears to cause a severe
disruption of microtubule-mediated events. At present we can-
not rule out the possibility that this might be due to the inhi-
bition of the function of some other proteins, such as CENP-E,
in vivo by noscapine in some unknown way.
FIG. 5. Effects of gradient concen-
trations of noscapine on the mor-
phology of the mitotic spindle in
HeLa cells. In normal metaphase all
chromosomes are aligned at the met-
aphase plate of a bipolar spindle. 6.7 nM
vinblastine-arrested cells have bipolar
mitotic spindles; most of these cells show
completion of chromosome alignment
(72.7%), and a small fraction of them
show incomplete alignment (14.5%). 1 M
noscapine does not have a detectable ef-
fect on mitotic arrest. Mitotic cells ar-
rested by 10, 20, or 100 M noscapine all
have nearly normal bipolar spindles al-
though most of the chromosomes in these
cells are aligned at the metaphase plate,
many remain near the spindle poles. Bar,
10 m.
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Noscapine Causes Loss of Tension across Kinetochore
Pairs—It has generally been believed that the attachment be-
tween kinetochores of chromosomes and the plus ends of mi-
crotubules is highly dynamic, in that tubulin subunits can
assemble and disassemble at the kinetochore region (31). Phys-
ical tension is generated across kinetochore pairs following
microtubule attachment to kinetochores. The amount of ten-
sion generated between kinetochore pairs is probably regulated
by the combined action of microtubule dynamics and microtu-
bule motors within the vicinity of kinetochores (32, 33).
Noscapine, which dampens the dynamic growth and shortening
of microtubules, could impact upon the tension between kine-
tochore pairs and/or the attachment between kinetochores and
microtubules. Either of these effects might in turn activate the
spindle checkpoint, thereby blocking mitotic progression.
The sister kinetochore distance is a good measure of the
tension exerted upon kinetochore pairs by attached microtu-
bules (33–35). Immunofluorescent staining of sister centro-
meres followed by confocal microscopy allowed us to clearly
resolve the kinetochores of sister chromatids (see insets in Fig.
6A). To examine the effect of noscapine on the kinetochore
tension, we measured the distance between sister kinetochores
in mitotic cells treated or untreated with 20 M noscapine (Fig.
6B). We found that the distance between kinetochore pairs in
noscapine-treated mitotic cells was 1.35  0.34 m on average,
which was 30% less than that in control cells, indicating the
reduction of tension by noscapine treatment. In addition, the
sister kinetochore distance of chromosomes near the spindle
poles (group II) was slightly less than that of chromosomes
aligned at the equatorial metaphase plate (group I). The 30%
reduction of kinetochore tension by noscapine treatment was
comparable with those obtained in low dose vinblastine-treated
FIG. 6. Elimination of kinetochore tension by noscapine treatment. A, double color immunofluorescent images showing centromeres
(green) and microtubules (red) in metaphase HeLa cells. Cells treated with 20 M noscapine are compared with those untreated (Control) or treated
with 6.7 nM vinblastine or 20 M nocodazole. Insets are magnified images of representative sister kinetochores from which the sister kinetochore
distance is measured. In the panel showing noscapine treatment, two insets represent kinetochore pairs of aligned (left inset) and unaligned
chromosomes (right inset), respectively. Note that centromeres in the untreated metaphase cells were distinctly elongated; they were highly
symmetric structures around the metaphase plate in typical vinblastine-arrested metaphase cells. In nocodazole-treated cells, microtubules were
completely depolymerized, and centromeres were scattered in the cell. In contrast, in noscapine-arrested metaphase cells centromeres were either
around the metaphase plate or near spindle poles. Bar, 10 m. B, noscapine treatment caused a reduction of sister kinetochore distance, indicating
loss of tension at kinetochores. Sister kinetochore distances were measured as diagrammed in the figure and described under “Experimental
Procedures.” Note that in noscapine-arrested cells, the sister kinetochore distance of chromosomes aligned at the center (group I) was larger than
that of chromosomes near the spindle poles (group II), but both of them were comparable with that in vinblastine-arrested cells and in
nocodazole-treated cells that lacked microtubules.
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cells (31% reduction) and in cells in which kinetochore tension
was completely eliminated by high dose nocodazole (34% reduc-
tion) (Fig. 6B). Our results were also in agreement with those
reported earlier in cells treated with paclitaxel, vinblastine, or
nocodazole (24, 35, 36). Our preliminary electron microscopic
analysis showed that the number of kinetochore microtubules of
the aligned chromosomes was also reduced by noscapine treat-
ment.2 This indicates that the loss of tension by noscapine treat-
ment can be attributed not only to the suppression of microtubule
dynamics but to fewer microtubules attached per kinetochore.
Activation of the Spindle Checkpoint by Noscapine Treat-
ment—We next investigated the spindle checkpoint status in
noscapine-arrested cells by examining the cellular localization
patterns of three checkpoint proteins, Mad2, Bub1, and BubR1.
All of these proteins are essential for spindle checkpoint control
in human cells (28, 37–40). In prometaphase Mad2 is localized
to the kinetochore region, whereas in metaphase it is no longer
detectable at kinetochores (Ref. 41; also see Fig. 7, Control).
Strikingly, we observed that in noscapine-arrested mitotic
cells, Mad2 was present at the kinetochores on chromosomes
that were near the spindle poles but was not detectable on
chromosomes aligned at the metaphase plate (Fig. 7). In con-
trast, Bub1 and BubR1 were localized to the kinetochores on
both groups of chromosomes (Fig. 8). Similar localization pat-
terns of Mad2 and Bub1/BubR1 were found in low dose vin-
blastine-arrested mitotic cells (Figs. 7 and 8). Nevertheless, in
cells treated with either noscapine or vinblastine, the kineto-
chores on aligned chromosomes showed a slight reduction in
Bub1 and BubR1 staining compared with those unaligned,
although the difference was not as dramatic as seen for Mad2.
We then used quantitative immunofluorescence microscopy
to further compare the difference among these checkpoint pro-
teins at kinetochores on aligned and unaligned chromosomes.
Clearly, the fluorescence intensity of Mad2 at kinetochores on
unaligned chromosomes was 138-fold higher than that on
aligned chromosomes in cells treated with noscapine (Table II
and Fig. 9). In these cells, the levels of Bub1 and BubR1 at
kinetochores decreased by 3.7- and 3.9-fold, respectively, upon
metaphase alignment. As a comparison, in 6.7 nM vinblastine-
treated cells, the intensity of Mad2, Bub1, and BubR1 de-
creased by 152-, 4.0-, and 4.3-fold, respectively, upon chromo-
some alignment (Table II and Fig. 9). These values were in
excellent agreement with those reported by Hoffman et al. (23)
for the changes of Mad2 and BubR1 intensity in PtK1 cells. In
addition, the 3–4-fold reductions of Bub1 and BubR1 staining
at kinetochores of vinblastine- and noscapine-treated cells were
also similar to the reduction seen for these proteins at aligned
kinetochores of non-drug-treated cells. Our data thus support
the idea that Mad2 and Bub1/BubR1 respond to the kineto-
chore-microtubule attachment and/or tension to different
degrees.
DISCUSSION
Noscapine is a novel microtubule interacting agent that ar-
rests mitosis in dividing mammalian cells (13). In the present
study we found that noscapine did not significantly affect the in
vitro assembly of tubulin into microtubules even at concentra-
tions as high as 100 M. At such a high concentration, many
other known microtubule inhibitors (e.g. paclitaxel, nocodazole,
colchicine, vinblastine, etc.) strongly promote or inhibit micro-
tubule assembly (6, 42). Our data further demonstrated that
noscapine, as predicted from the in vitro microtubule behavior,
did not significantly change the tubulin polymer/monomer ra-
tios in HeLa cells. The minor effect of noscapine on microtubule
assembly was also predicted by the nature of its alteration of
microtubule dynamics at steady state in vitro. Microtubule
growing and shortening rates and their extents were both
slightly inhibited by noscapine, and the catastrophe frequency
was reduced, resulting in an increased attenuated phase. How-
ever, at the concentrations used for the above studies, noscap-
ine efficiently blocked cells in mitosis. Thus, these findings
clearly show that noscapine interacts with microtubules in a
manner distinct from many other microtubule drugs. These
results also support the hypothesis that the mechanisms by
which anti-microtubule drugs inhibit cell division and prolifer-2 J. Zhou and H. C. Joshi, unpublished observation.
FIG. 7. Localization patterns of the spindle checkpoint protein
Mad2 within the vicinity of kinetochores. Cells treated with 20 M
noscapine were compared with control metaphase cells and 6.7 nM
vinblastine-arrested mitotic cells. Mad2 and DNA were stained and
visualized as described under “Experimental Procedures.” Note that in
mitotic cells arrested by noscapine or vinblastine, Mad2 was recruited
to the kinetochores on chromosomes near the spindle poles but was not
found on chromosomes aligned at the metaphase plate. Bar, 10 m.
FIG. 8. Double color staining of Bub1/BubR1 (green) and DNA
(red) showing the localization patterns of Bub1 and BubR1
within the vicinity of kinetochores. Cells were treated as described
in the legend for Fig. 7 and stained and visualized as described under
“Experimental Procedures.” Bar, 10 m.
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ation might lie in the suppression of spindle microtubule dy-
namics (43).
Chemical compounds that suppress spindle dynamics with-
out increasing or decreasing microtubule polymer mass have
been very powerful agents in the direct testing of the roles of
microtubule dynamics in mitosis (6). Because these drugs affect
microtubule assembly and dynamics through diverse mecha-
nisms, their use and action in the study of mitosis collectively
might provide invaluable information about the role that mi-
crotubules play in the progression of mitosis. In this study we
have explored the use of noscapine in analyzing mitosis. The
finding that noscapine causes chromosome congression failure
is very intriguing. It is possible that suppression of microtubule
dynamics by noscapine might affect the chromosome-capturing
ability of microtubules, which is essential for chromosome con-
gression and subsequent alignment at the metaphase equator.
Alternatively, the interaction of noscapine with microtubules
might influence the interaction of microtubules with motor
molecules that is required for chromosome movement to the
equatorial center (44, 45). It has been demonstrated that chro-
mosome congression is not a smooth, continuous movement of
chromosomes from the poles to the equatorial plate, but rather
it is a nonlinear journey involving frequent oscillations both
toward and away from the poles (32, 46–48). Such movements
would necessarily require frequent transitions between micro-
tubule growth and shortening. Thus, the most likely explana-
tion is that the inhibition of the microtubule catastrophe fre-
quency by noscapine and the increase in the fraction of time
that the microtubules remain in the attenuated state delay or
prevent chromosome congression.
Physical tension across kinetochore pairs, another property
closely related to the dynamic instability of microtubules, is
also thought to be critical for chromosome movement during
mitosis. Our results demonstrate that alteration of microtubule
dynamics by noscapine does not cause major changes in spindle
morphology, and yet the altered dynamics results in the loss of
kinetochore tension, as revealed by the reduction of sister kin-
etochore distance. In addition, our preliminary electron micro-
scopic analysis shows that noscapine treatment also leads to
reduction in the number of kinetochore microtubules of the
aligned chromosomes.2 Thus, the loss of tension by noscapine
treatment can be attributed not only to the suppression of
microtubule dynamics but also to fewer microtubules attached
per kinetochore. In this study, we found that tension on the
TABLE II
Fluorescence intensity of kinetochores on aligned and unaligned chromosomes
Noscapine Vinblastine
Aligned Unaligned Aligned Unaligned
Mad2
Number 63 31 42 28
Mean  S.D. 1943  1282 268539  69442 1828  1301 277646  76414
Relative ratio 1 138 1 152
Bub1
Number 48 37 45 24
Mean  S.D. 41877  19612 156123  48983 39825  16654 160162  78266
Relative ratio 1 3.7 1 4.0
BubR1
Number 52 36 49 27
Mean  S.D. 42733  20878 164871  51323 42061  23887 179428  59029
Relative ratio 1 3.9 1 4.3
FIG. 9. Quantitation of the fluores-
cence intensity of individual kineto-
chores. A, diagram showing the method
used to measure kinetochore fluorescence
intensity as described under “Experimen-
tal Procedures.” B, quantitative analysis
of the changes in kinetochore fluorescence
of unaligned chromosomes compared with
aligned chromosomes. Kinetochores were
stained with antibodies against Mad2,
Bub1, and BubR1, respectively. Relative
Fluorescence Intensity refers to the values
relative to those for kinetochores on
aligned chromosomes, as summarized in
Table II.
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kinetochores of chromosomes that failed to align at the equa-
torial mid-plate but rather remained near the spindle poles was
even less than that of chromosomes aligned at the metaphase
equator. This is understandable because most of the unaligned
chromosomes might be mono-oriented without attaching to the
opposite spindle pole, whereas those that are aligned might
associate with microtubules from the two poles. These results
are also consistent with results obtained with substoichiomet-
ric nanomolar concentration of vinblastine, which also damp-
ens spindle microtubule dynamics without perturbing bipolar
spindle association with kinetochores (35, 36).
The goal of the cell division cycle is to produce two genetically
identical cells from one. To ensure fidelity in the transmission
of genetic information, the cell must be able to detect errors
before chromosome segregation at anaphase. This is achieved
by the spindle checkpoint, which prevents the onset of an-
aphase until all of the chromosomes are correctly attached by
spindle microtubules and proper tension is applied to the chro-
mosomes (33, 34). Our data show that the spindle checkpoint
proteins Mad2, Bub1, and BubR1 all respond, yet to different
degrees, to kinetochore-microtubule attachment and/or ten-
sion. It will be of great importance to investigate further how
the attachment and/or tension signal the spindle checkpoint
machinery as well as how various checkpoint proteins partici-
pate in these processes.
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